Table of Contents Author Guidelines Submit a Manuscript
Advances in Urology
Volume 2008, Article ID 193694, 3 pages
http://dx.doi.org/10.1155/2008/193694
Case Report

Priapism, Ecstasy, and Marijuana: Is There a Connection?

1School of Medicine, University of Queensland, Brisbane 4006, Queensland, Australia
2Department of Internal Medicine, Princess Alexandra Hospital, Brisbane 4102, Queensland, Australia

Received 27 July 2007; Accepted 23 December 2007

Academic Editor: Steven B. Brandes

Copyright © 2008 Quan T. Tran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. K. Montague, J. Jarow, and G. A. Broderick et al., “American urological association guideline on the management of priapism,” Journal of Urology, vol. 170, no. 4, part 1, pp. 1318–1324, 2003. View at Publisher · View at Google Scholar · View at PubMed
  2. T. F. Lue, “Physiology of penile erection and pathophysiology of erectile dysfunction and priapism,” in Campbell's Urology, P. C. Walsh, A. B. Retik, and E. D. Vaughan, Eds., W.B. Saunders, Philadelphia, Pa, USA, 8th edition, 2002.
  3. N. Dublin and A. H. Razack, “Priapism: ecstasy related?,” Urology, vol. 56, no. 6, p. 1057, 2000. View at Publisher · View at Google Scholar
  4. U. D. McCann, Z. Szabo, U. Scheffel, R. F. Dannals, and G. A. Ricaurte, “Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings,” The Lancet, vol. 352, no. 9138, pp. 1433–1437, 1998. View at Publisher · View at Google Scholar
  5. A. R. Green, A. O. Mechan, J. M. Elliott, E. O'Shea, and M. I. Colado, “The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”),” Pharmacological Reviews, vol. 55, no. 3, pp. 463–508, 2003. View at Publisher · View at Google Scholar · View at PubMed
  6. K. E. Andersson and G. Wagner, “Physiology of penile erection,” Physiological Reviews, vol. 75, no. 1, pp. 191–236, 1995.
  7. H. A. Fink, R. MacDonald, I. R. Rutks, and T. J. Wilt, “Trazodone for erectile dysfunction: a systematic review and meta-analysis,” BJU International, vol. 92, no. 4, pp. 441–446, 2003. View at Publisher · View at Google Scholar
  8. L. A. Dent, W. C. Brown, and J. D. Murney, “Citalopram-induced priapism,” Pharmacotherapy, vol. 22, no. 4, pp. 538–541, 2002. View at Publisher · View at Google Scholar
  9. R. Z. Samuel, “Priapism associated with venlafaxine use,” Journal of the American Academy of Child & Adolescent Psychiatry, vol. 39, no. 1, pp. 16–17, 2000. View at Publisher · View at Google Scholar
  10. E. H. Rand, “Priapism in a patient taking sertraline,” Journal of Clinical Psychiatry, vol. 59, no. 10, p. 538, 1998.
  11. E. M. Hull, J. W. Muschamp, and S. Sato, “Dopamine and serotonin: influences on male sexual behavior,” Physiology & Behavior, vol. 83, no. 2, pp. 291–307, 2004. View at Publisher · View at Google Scholar · View at PubMed
  12. H. Horita, Y. Sato, and H. Adachi et al., “Effects of levodopa on nocturnal penile tumescence: a preliminary study,” Journal of Andrology, vol. 19, no. 5, pp. 619–624, 1998.
  13. P. Danjou, L. Alexandre, D. Warot, L. Lacomblez, and A. J. Puech, “Assessment of erectogenic properties of apomorphine and yohimbine in man,” British Journal of Clinical Pharmacology, vol. 26, no. 6, pp. 733–739, 1988.
  14. M. R. Melis, S. Succu, and F. Sanna et al., “PIP3EA and PD-168077, two selective dopamine D4 receptor agonists, induce penile erection in male rats: site and mechanism of action in the brain,” European Journal of Neuroscience, vol. 24, no. 7, pp. 2021–2030, 2006. View at Publisher · View at Google Scholar · View at PubMed
  15. C. J. Hillard, “Endocannabinoids and vascular function,” Journal of Pharmacology and Experimental Therapeutics, vol. 294, no. 1, pp. 27–32, 2000.
  16. S. Succu, M. S. Mascia, F. Sanna, T. Melis, A. Argiolas, and M. R. Melis, “The cannabinoid CB1 receptor antagonist SR 141716A induces penile erection by increasing extra-cellular glutamic acid in the paraventricular nucleus of male rats,” Behavioural Brain Research, vol. 169, no. 2, pp. 274–281, 2006. View at Publisher · View at Google Scholar · View at PubMed
  17. D. Braida, S. Iosuè, S. Pegorini, and M. Sala, “3,4 methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system,” Pharmacological Research, vol. 51, no. 2, pp. 177–182, 2005. View at Publisher · View at Google Scholar · View at PubMed
  18. E. L. Gardner and S. R. Vorel, “Cannabinoid transmission and reward-related events,” Neurobiology of Disease, vol. 5, no. 6, pp. 502–533, 1998. View at Publisher · View at Google Scholar · View at PubMed